EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The lysosomal permeability test modified for toxicity testing with cultured heart endothelioid cells






Histochemical Journal 7(2): 115-126

The lysosomal permeability test modified for toxicity testing with cultured heart endothelioid cells

A modified lysosomal fragility test is described which is suitable for use with cultured cells. The permeability (fragility) of the lysosomal membranes of the cells to the substrate beta-glycerophosphate is measured by assessing the degree of particulate lysosomal straining seen after exposing the cells to the Gomori acid phosphatase staining reaction under carefully controlled conditions. Monolayer cultures of endothelioid cells from the hearts of neonatal rats have been used in all experiments. The time-course of lysosomal straining for cells exposed to various treatments (normal saline, isotonic sucrose, 0.25 m sucrose, distilled water, acetate buffer pH 5.0, cold acetone, neutral formalin, acetic-ethanol, Triton X-100, hydrocortisone, choloroquine and vitamin A) was compared with that of control cells stained under identical conditions. Statistical differences in staining between the test and control cells were determined by the Wilcoxin Signed Rank Test and also by regression analysis following a transformation designed to allow for the saturation character of the reaction. The success of the modified technique depends upon meticulous methodology. It is capable of demonstrating both lysosomal membrane labilization and stabilation, second- and third-stage lysosomal activation, and apparent lysosomal enzyme loss or destruction in situ. The technique also allows the degree of reversible or first-stage lysosomal activation to be subdivided on an almost continous basis and is suitable for investigating the effects of drugs and other agents on the integrity of the lysosome in situ.

(PDF 0-2 workdays service: $29.90)

Accession: 006712619

PMID: 47854



Related references

Cholesterol and beta-lipoprotein on lipid inclusions and lysosomal and mitochondrial permeability of cultured heart muscle and endothelioid cells. Research Communications in Chemical Pathology and Pharmacology 12(4): 789-792, 1975

A permeability test for the study of mitochondrial injury in in vitro cultured heart muscle and endothelioid cells. Histochemical Journal 7(1): 45-56, 1975

Clofibrate enhancement of stearate-induced permeability of lysosomes and mitochondria in cultured heart muscle and endothelioid cells. Research Communications in Chemical Pathology and Pharmacology 7(1): 201-204, 1974

Toxicity of saturated and unsaturated free fatty acids for cultured rat heart muscles and endothelioid cells. 1979

Toxicity of free fatty acids for cultured rat heart muscle and endothelioid cells. iI. unsaturated long chain fatty acids. Toxicology 11 (2) 119-125, 1978

Toxicity of free fatty acids for cultured rat heart muscle and endothelioid cells. II. Unsaturated long-chain fatty acids. Toxicology 11(2): 119-125, 1978

Toxicity of free fatty acids for cultured rat heart muscle and endothelioid cells. I. Saturated long-chain fatty acids. Toxicology 11(2): 109-117, 1978

Toxicity of free fatty acids for cultured rat heart muscle and endothelioid cells. i. saturated long chain fatty acids. Toxicology 11 (2) 107-117, 1978

Toxicity of free fatty acids for cultured rat heart muscle and endothelioid cells part 1 saturated long chain fatty acids. Toxicology 11(2): 109-118, 1978

Toxicity of free fatty acids for cultured rat heart muscle and endothelioid cells part 2 unsaturated long chain fatty acids. Toxicology 11(2): 119-126, 1978